Officials said on Wednesday that the number of children who have been hospitalized in New York City with symptoms consistent with a rare disease possibly linked to the coronavirus has nearly quadrupled to 64. Health officials said the illness has features of Kawasaki disease, a serious illness previously noted in children with COVID-19 in the United…
There is still much to learn about the novel coronavirus, including a wide range of symptoms that appears to be expanding. Common symptoms of the respiratory illness include fever, cough, shortness of breath and chills, but some doctors have reported less obvious symptoms in some patients — including what some are calling "COVID toes" and…
There is still much to learn about the novel coronavirus, including a wide range of symptoms that appears to be expanding. Common symptoms of the respiratory illness include fever, cough, shortness of breath and chills, but some doctors have reported less obvious symptoms in some patients — including what some are calling "COVID toes" and…
There is still much to learn about the novel coronavirus, including a wide range of symptoms that appears to be expanding. Common symptoms of the respiratory illness include fever, cough, shortness of breath and chills, but some doctors have reported less obvious symptoms in some patients — including what some are calling "COVID toes" and…
Health officials now say there are at least nine symptoms associated with the virus. By Johanna SilverPublished on 4/29/2020 at 11:53 AMThe Centers For Disease Control and Prevention (CDC) added six new symptoms to its list of signs that a person may have coronavirus. Prior to the update, the CDC said that fever, cough and shortness…
3 min read This story is part of a series on 10 life-saving medical breakthroughs. Click here to read the rest. ANTONIO TORRES, A 24-year-old from Denver, used to spend six hours each day bathing and meticulously wrapping the red, raw skin along his shoulders and spine. “My wounds take up a large percentage of
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has recommended granting marketing authorization for Moderna’s new RNA-based vaccine, mNexspike, for preventing COVID-19 in people aged 12 years or older. The vaccine was approved in May 2025 by the US FDA for individuals aged 65 years or older or aged 12-64 years
KFF Health News chief Washington correspondent Julie Rovner discussed Affordable Care Act subsidies on Crooked Media’s What a Day on Dec. 10 and on Slate’s What Next on Dec. 9. Click here to hear Rovner on What a Day. Click here to hear Rovner on What Next. KFF Health News Washington health policy reporter Amanda